Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TL-118 in Pancreatic Cancer
NCT01659502Phase 2Unknown
- Sponsor
- Tiltan Pharma
- Start
- Dec 2013
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
A Phase 2 trial of TL-118 in pancreatic cancer (PC), sponsored by Tiltan Pharma. Status: unknown.
02
Drugs
TL-118
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01659502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01659502.